Dentsply Sirona (XRAY)

• Market cap: $3.72B
• 1 day: 1.25%
• 5 days: -4.45%
• 1 month: 0.97%
• 3 months: -28.87%
• 6 months: -26.52%
• Year to date: -47.52%
• 1 year: -45.03%
• 5 years: -67.11%
• 10 years: -65.43%
• Sector: Healthcare
• Industry: Dental Equipment & Supplies

About: Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (manufactured dental consumables and lab products) and Sirona Dental Systems (manufactured technologically-advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantation. It distributes two-thirds of its dental consumables, technology and equipment through third-party distributors and the remaining portfolio is either sold to labs and offices through the firm's salesforce or directly to consumers (such as Byte clear aligner).

Employees: 15,000

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

33% more funds holding in top 10

Funds holding in top 10: 3 [Q2] → 4 (+1) [Q3]

30% more call options, than puts

Call options by funds: $20.7M | Put options by funds: $15.9M

3% more first-time investments, than exits

New positions opened: 62 | Existing positions closed: 60

2% more capital invested

Capital invested by funds: $5.46B [Q2] → $5.58B (+$113M) [Q3]

1% more funds holding

Funds holding: 374 [Q2] → 376 (+2) [Q3]

3.8% less ownership

Funds ownership: 105.61% [Q2] → 101.81% (-3.8%) [Q3]

21% less repeat investments, than reductions

Existing positions increased: 117 | Existing positions reduced: 148

Research analyst outlook

7 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $21 12% upside
• Avg. target: $25 34% upside
• High target: $29 55% upside

7 analyst ratings

• positive: 5 71%
• neutral: 2 29%
• negative: 0 0%

Morgan Stanley Erin Wright 48% 1-year accuracy 11 / 23 met price target	23% upside $23	Overweight Maintained	17 Dec 2024
Mizuho Steven Valiquette 20% 1-year accuracy 1 / 5 met price target	12% upside $21	Neutral Initiated	4 Dec 2024
UBS Kevin Caliendo 56% 1-year accuracy 9 / 16 met price target	44% upside $27	Buy Maintained	3 Dec 2024
Barrington Research Michael Petusky 43% 1-year accuracy 29 / 68 met price target	28% upside $24	Outperform Maintained	8 Nov 2024
Baird Jeffrey Johnson 0 / 0 met price target	28% upside $24	Neutral Maintained	8 Nov 2024